Michigan Nursing Professionals CE Package
- Meet all your state CE requirements
Included Courses
Courses included in this package. Click on a course to learn more.
- Responsible Opioid Prescribing for Chronic Pain Management 3
Course Release Date: 7/1/2024
Course Overview
This continuing education program is designed to characterize the best practices for the use of prescription opioid medications intended for treating chronic pain, within the constraints emphasized by the FDA. It will also characterize other strategies to combat the misuse of prescription medications. This program will provide healthcare professionals with a solid foundation for responsible opioid use and include vigilant monitoring designed to identify misuse.
- Attention Deficit Hyperactivity Disorder 5 2
Course release date: 10/1/2024
Course Overview
Attention deficit hyperactivity disorder (ADHD) is a debilitating psychiatric illness affecting approximately 4% to 12% of the population. Characterized by persistent problems with distractibility, impulsivity, and/or hyperactivity, ADHD has a significant effect on day-to-day functioning and quality of life. Unfortunately, ADHD often goes unrecognized. Patients may hesitate to disclose their symptoms, and physicians unfamiliar with this disorder may confuse its manifestations with other psychiatric illnesses. Common comorbidities can further cloud the diagnosis. This course will cover the epidemiology, diagnostic criteria, pathophysiology, and differential diagnosis of ADHD. It will review the first-line treatments, recommended duration of therapy, and options for patients who do not respond to initial therapy. Finally, it will address the roles of other therapeutic options, such as behavioral therapy. - Frontotemporal Dementia 2 1
Course release date: 11/1/2024
Course Overview
Frontotemporal dementia (FTD) is a group of degenerative brain disorders causing progressive deterioration in behavior, language, and/or movement. There are presently approximately 60,000 people with FTD in the United States. Onset generally occurs between 50 and 70 years of age, making FTD one of the most common presenile dementias. FTD affects the frontal and temporal lobes of the brain, which control emotions, judgment, personality, memory and language. The clinical diagnosis of FTD can be challenging, as some symptoms overlap with Alzheimer disease and other forms of dementia. FTD can be categorized based on its primary symptoms into three basic types: behavioral variant FTD, primary progressive aphasia, and progressive motor decline. Although most FTD does not appear to be inherited, genetics does play a role in a significant minority of cases. There is no effective treatment or cure for FTD, but there are strategies for management of symptoms. This course will discuss the possible causes and pathophysiology, diagnosis, and management strategies for FTD. - Prediabetes: An Opportunity to Prevent Diabetes 15 7
Course release date: 2/1/2024
Course Overview
Prediabetes is a condition that affects more than one-third of the adult population in the United States. As a major risk factor for diabetes and cardiovascular disease, its potential toll on the healthcare system and on the individual is significant. Also known as "glucose intolerance," prediabetes is diagnosed when the blood glucose is higher than normal but does not meet the diagnostic criteria for diabetes. Results from the Diabetes Prevention Program showed that the onset of diabetes could be delayed or prevented with lifestyle interventions in subjects with glucose intolerance who were also overweight and sedentary. This course will describe the pathophysiology and risks associated with prediabetes and diabetes. It will also discuss the lifestyle interventions recommended by the Diabetes Prevention Program. Because lifestyle change can be challenging, the course will provide strategies for motivating and helping patients making these changes.